Palisade Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Palisade Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-62,816	Closed	-$3.36M	–	584
2016 Q1	$3.36M	Sell	62,816 -26,749	-30%	-$1.97M	0.11%	268
2015 Q4	$10.1M	Buy	89,565 +6,302	+8%	+$694K	0.33%	100
2015 Q3	$9.8M	Buy	+83,263	New	+$10.9M	0.29%	125

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Palisade Capital Management's ANAC Position: Q2 2016 in Review

Palisade Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 62,816 shares — an estimated $3.36M sold.

Palisade Capital Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $10.1M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Palisade Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Palisade Capital Management sold 62,816 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $3.36M.
Palisade Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Palisade Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $10.1M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Palisade Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.